CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.

Source:http://linkedlifedata.com/resource/pubmed/id/19442564

Download in:

View as

General Info

PMID
19442564